경피적 산소농도 측정 시스템 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Transcutaneous Oximetry Systems Market reached USD 213.4 million by 2024 and is expected to exhibit a steady growth rate of 5.4% CAGR from 2025 to 2034. This market growth is driven by a combination of factors, including the increasing prevalence of peripheral artery disease, the rapid advancements in non-invasive monitoring technologies, and the aging population. As the need for effective wound care continues to rise, more healthcare providers are turning to transcutaneous oximetry systems to monitor oxygen levels in tissues. These systems allow for timely and accurate readings, essential for early detection and preventive care.

Innovations in sensor technology and wireless connectivity are making these systems more efficient and accessible across a wide range of healthcare settings. From hospitals to outpatient facilities, the growing adoption of transcutaneous oximetry systems reflects a larger trend toward precision medicine and patient-centered care. With healthcare providers focused on improving diagnostic accuracy and optimizing workflows, investments in these advanced monitoring solutions are increasing. Additionally, regulatory changes and growing awareness about vascular and respiratory conditions are helping to shape market dynamics. The rising demand for home healthcare and remote monitoring solutions further fuels the growth of the market, as patients and caregivers seek real-time, at-home monitoring of oxygenation levels.

By channel type, the market is divided into multichannel and single-channel systems. In 2024, multichannel systems are projected to generate USD 156.5 million in revenue. Their ability to measure oxygen levels at multiple sites simultaneously boosts diagnostic accuracy and enhances efficiency, especially for patients with complex health conditions. By eliminating the need for multiple individual readings, these systems streamline clinical workflows and provide comprehensive data on tissue oxygenation, driving their popularity in high-volume healthcare facilities.

In terms of end use, hospitals lead the market with the largest share in 2024, with revenue expected to reach USD 153.8 million by 2034. Hospitals are increasingly adopting transcutaneous oximetry systems to monitor patients with chronic conditions such as peripheral vascular disease, diabetes, and respiratory disorders. These systems offer continuous, non-invasive assessments of tissue oxygenation, enabling timely interventions that improve patient outcomes. The growing integration of these devices in specialized hospital departments, such as wound management, post-surgical monitoring, and vascular assessments, is further fueling demand.

The U.S. transcutaneous oximetry systems market generated USD 97 million in 2024, with a projected CAGR of 4.1% through 2034. The U.S. remains a global leader in medical technology innovation, driving the widespread adoption of transcutaneous oximetry systems across various healthcare sectors. Improvements in sensor precision, portability, and wireless connectivity are making these systems more user-friendly and efficient. As the U.S. healthcare system shifts towards preventive care, the demand for these devices is expected to grow significantly, contributing to regional market expansion.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of peripheral vascular disorders and wound healing disorders
    • 3.2.1.2 Rising focus towards patient monitoring during diagnosis and treatment
    • 3.2.1.3 Technological advancements
    • 3.2.1.4 Growing awareness regarding use of transcutaneous oximetry systems for preterm infants
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory policies
    • 3.2.2.2 High cost associated with transcutaneous oximetry systems
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Pricing analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis
• 3.10 Gap analysis
• 3.11 Future market trends
• 3.12 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Channel Type, 2021 — 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Multichannel
• 5.3 Single channel

Chapter 6 Market Estimates and Forecast, By Application, 2021 — 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Peripheral vascular disorders
• 6.3 Diabetic foot ulcers
• 6.4 Preterm births
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Diagnostic centers
• 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 ADVIN
• 9.2 Cephalon
• 9.3 Drager
• 9.4 ELCAT
• 9.5 medicap
• 9.6 PERIMED
• 9.7 PHILIPS
• 9.8 RADIOMETER
• 9.9 sentec